Health Innovation Summit 2022

As Senior Director over Editorial, Aurora Aguilar manages news and features for WebMD's consumer readers and for Medscape's medical professional audience. WebMD attracts 75 million unique users a month, while Medscape reaches 676,000 clinician subscribers. Previously, Aguilar was editor-in-chief of Modern Healthcare, a news outlet and events outlet targeting healthcare C-suite executives. During her leadership, subscribers grew to record numbers and the organization was lauded for providing thoughtful, thorough coverage of the industry’s most pressing challenges. Aguilar has also led the newsroom at Chicago Public Media, the NPR affiliate in Chicago, where she served as news director and senior project editor for Front & Center, a project funded by the Joyce Foundation. She started her tenure at Chicago Public Media as lead producer of the station’s flagship show. Throughout her career, she has received recognition for exemplary journalism by the National Association of Black Journalists, the Society of Professional Journalists, the Associated Press Broadcast Awards, the Radio Television Digital News Association, among other organizations. However, she is most proud of her James Beard award for radio production, which is hanging in her kitchen and which Aguilar passes off as a culinary award.

Toyin Ajayi, MD is co-founder and CEO of Cityblock Health, a tech-enabled, value-based healthcare provider for Medicaid, dually-eligible and lower-income Medicare beneficiaries in underserved communities. Cityblock’s model of care meets individuals where they are, delivering highly personalized medical care, behavioral health care, and social services to members in neighborhoods where it’s needed most. Prior to Cityblock, Ajayi served as Chief Medical Officer of Commonwealth Care Alliance, a nationally renowned integrated health plan and care delivery system for individuals eligible for both Medicare and Medicaid. In this role, she led clinical operations, spearheaded care delivery innovations, and oversaw multi-disciplinary teams of clinicians, community health workers and administrators. Ajayi received her undergraduate degree from Stanford University, an MPhil from the University of Cambridge and her medical degree, with Distinction in Clinical Practice, from King’s College London School of Medicine. Board certified in Family Medicine, she completed her residency training at Boston Medical Center and continues to practice primary care with a focus on patients with chronic, complex and end-of-life needs.

Lisa Alderson is the CEO and Co-Founder of Genome Medical, Inc., a digital health company and virtual medical practice transforming the delivery of healthcare by enabling access to genomic-based medicine for patients everywhere. Lisa has 20 years of experience building early-stage companies with a focus on technology, consumer and life sciences businesses. Prior to Genome Medical, Lisa served as the chief commercial officer and chief strategy officer of Invitae. a rapidly growing genetic information company. She was part of the start-up team at Genome Health Inc., president of Cinema Circle, Inc., and the former manager of strategic planning at The Walt Disney Co.

Rob Allen, FACHE, chief operating officer, Intermountain Healthcare, has been named as one of the top 25 COOs in healthcare by Modern Healthcare. He’s leading Intermountain’s nationally recognized operational work to connect with patients and healthcare consumers when, where, and how they want to receive care and services—including innovative virtual and telehealth services, and ambulatory surgery centers. He’s collaborating with Intermountain leaders, clinicians, and caregivers to redefine value-based care—improving health and making healthcare more effective, affordable, and accessible. Further, Allen leads Intermountain’s operational best practices and continuous improvement culture to improve safety, quality, and affordability. In addition to Allen’s 25-plus years of executive leadership at Intermountain, he’s also held CEO roles at hospitals and health systems in Wyoming, New Jersey, and Massachusetts. A fellow of the American College of Healthcare Executives, he has served on many foundations, chambers, and service boards. He earned a Master of Business Administration degree from Utah State University and a Bachelor of Science Degree in Operations Management from Brigham Young University.

Anne Aslett is the global CEO of the Elton John AIDS Foundation (EJAF) which she has served for almost 20 years. As International Development Director to EJAF UK, she managed more than £60m in grants to programmes in Europe, Africa and Asia, before taking over the UK Foundation as its Executive Director in 2008. When the US and UK Foundations merged their operations in 2018, Anne assumed her current role. During Aslett’s tenure Foundation has become the 6th largest AIDS funder globally; has saved the lives of over 5m of the most marginalised people in the world and raised awareness of HIV amongst more than 100m people.

Dawn Barry is a veteran of the biotech industry and an advocate for girls and women in STEM professions. Her current company, Luna, has received numerous awards from notable institutions including the Word Economic Forum and Fast Company for redesigning the biomedical research model by bridging collectives of people with researchers through socially responsible health data sharing. Prior to starting Luna, Dawn spent 12 years helping build Illumina, where she ultimately served as the Vice President of Applied Genomics and led pioneering teams in precision medicine, translational genomics, population genomics, and clinical screening, among others. Barry’s accomplishments include being named San Diego Business Journal’s 2017 Business Woman of the Year, giving a talk at TEDxSanDiego 2016, and receiving Girl Scouts San Diego Cool Women award in 2019. She serves on the Board of the Alzheimer’s Association San Diego/Imperial County Chapter, Cardea Bio, and the California Entrepreneurship Task Force, under the Governor’s Office of Business and Economic Development. Barry holds a BS in biology from the University of Vermont, where she earned a scholarship to play division one softball, and an MBA from the University of Connecticut School of Business.

Alicia Berkemeyer is responsible for all programs related to provider networks, medical management, provider compensation, quality and value-based programs, primary care and commercial pharmacy for Arkansas Blue Cross and Blue Shield and its affiliates. Berkemeyer joined Arkansas Blue Cross in 1989 and has held several positions in the areas of claims, customer service, sales and marketing and pharmacy. She has more than 30 years of experience in the healthcare industry with a focus on value based care, primary care and pharmacy. Berkemeyer played an instrumental role in Arkansas being chosen as one of only seven regions in the United States to participate in the federal Comprehensive Primary Care initiative and assisted our state in receiving significant funding from the Centers for Medicare Services Innovation Center in the form of a State Innovation Model grant. She currently serves on the, Cystic Fibrosis Board, University of Arkansas Little Rock Business Advisory Council, and the Divine Mercy Clinic Board.

Amit Bhagat has twenty-plus years of experience helping clients succeed by developing information management, governance, business intelligence, advanced analytics, organizational design, intelligent automation, and performance management strategies and solutions. In an era of increasing change and labor challenges, Bhagat has worked extensively with clients in healthcare organizations to develop and implement growth strategies as well as drive measurable improvement in their operational performance by combining complex and information-based technology solutions, culture, people, and processes, all working in concert. As CEO of Amitech, he leads the firm's client-facing and growth strategies and enjoys working with client executives in an advisory capacity to solve complex problems facing today's healthcare industry.

Justin Blake heads Edelman’s Global Leadership positioning offer, guiding leaders in telling their authentic stories in today's complex communications environment. Blake counsels CEOs and other executive-level leaders to develop differentiating and relevant messages and communicate them through a range of channels, including media, conferences, digital and direct-to-influencer engagement.​ Justin leads the Edelman Trust Institute, a global center for the study and cultivation of trust across business, government, media and civil society. The Institute produces the expanding Edelman Trust Barometer report series, and content and convenings to forward the understanding of how to build Trust. ​ A 20-year Edelman veteran, he has worked with, government officials, university presidents, NGO heads and numerous FORTUNE 500 CEOs and executives from across the globe.​ Blake leads Edelman’s client work at Davos, since 2002, advising CEOs and executives from more than 50 companies and organizations on their World Economic Forum engagement. ​ He served for four years as Managing Director, Corporate & Public Affairs, Edelman New York – leading 170 professions in the areas of corporate & financial communications, public affairs, corporate social responsibility, technology and employee engagement. ​ Prior to joining Edelman, he was Director of Communications for the New York City Partnership and Chamber of Commerce. At the Partnership, the city’s leading business organization made up of hundreds of CEO’s, Blake was responsible for all public relations and marketing. He was an assistant press secretary for the 1993 Presidential Inaugural Parade and has worked on various political campaigns, including Clinton/Gore 92, where he served as a press aide on the first national bus tour.

Adam Boehler is the founder and CEO of Rubicon Founders, an entrepreneurial healthcare investment firm focused on building and growing transformational companies. Boehler has extensive experience in investment, entrepreneurship, and innovation in both the private sector and in the US Government. Boehler founded three successful businesses. Most recently, he founded and served as CEO of Landmark Health, a company delivering around-the-clock medical care to chronically ill patients in their homes. While at Landmark, he was recruited to lead healthcare innovation for the United States, serving as Senior Advisor to the Secretary, Deputy Administrator of the Centers for Medicare & Medicaid Services (CMS), and Director of the Innovation Center at CMS (CMMI). Adam was also a founding member of Operation Warp Speed, a public-private partnership that ultimately led to the first COVID-19 vaccines in the U.S.

Joe Cardosi is the Founder and CEO of Free Market Health. Prior to launching Free Market Health, he held sales and strategy leadership roles within Walgreens Specialty Pharmacy (now, AllianceRx Walgreens Pharmacy).  Cardosi began his Walgreens career in health plan sales/account management where he was responsible for winning, retaining, and growing specialty pharmacy business with leading US health insurers. Prior to leaving AllianceRx WP, he was the Vice President of Payer Strategy and Sales, where he developed and executed the company’s payer strategy and led the field-based provider sales team. Before joining Walgreens, Cardosi managed the business aspects of the pharmacy benefit at Gateway Health (now Highmark Wholecare), a mid-sized managed Medicaid and Medicare health plan in Pittsburgh, PA. In this role, he led specialty pharmacy and home infusion provider strategy and contracting, as well as formulary strategy through direct rebate negotiation and management of pharmaceutical manufacturer relationships. Prior to that, Joe began his career in clinical and patient-facing roles at small and large specialty pharmacies.

Albert Chan, M.D., M.S is the Chief Digital Health Officer at Sutter Health, leading a team that implements clinical workflows and operational infrastructure to enable digital transformation at enterprise scale. Chan has a particular focus on the power of data to empower clinicians to provide better care and empower patients and families to have better health outcomes. Chan has received national recognition as one of Becker’s Physician Leaders to Know in 2019 and Chief Digital Officers to Know in 2022. Internationally, he Chan is a Fulbright Specialist and a 2017 Eisenhower Fellow, one of 20 U.S. citizens selected for membership into a global network of change leaders. As a primary care physician, Chan continues to be invigorated by his patients, inspiring the development and translation of innovative partnerships into practice. He earned a B.S. in Biological Sciences with Honors from Stanford University and an M.D. from the University of California, San Diego School of Medicine. After completing residency and chief residency in family medicine, he concurrently completed fellowships in Biomedical Informatics at Stanford and family medicine research at the University of California, San Francisco School of Medicine. Chan is an adjunct professor at the Stanford Center for Biomedical Informatics Research.

Adam Chekroud is President and Co-founder of Spring Health, based in New York City, and an Assistant Professor of Psychiatry at Yale University. His research seeks to improve treatment outcomes in mental health, and has been featured in the Lancet, JAMA Psychiatry, Lancet Psychiatry, and PNAS, and covered in the Wall Street Journal, Financial Times, BBC, CNN, and NPR.

Doug Danison is inspired by the transformative benefits that biotech innovation can bring to patients, families, physicians, and the healthcare system. He has more than 22 years of pharmaceutical and biotech experience, including roles with Eli Lilly, Amgen, Millennium/Takeda Oncology, bluebird bio, and now Bayer Cell & Gene Therapy (CGT). He has led or overseen the preparation of market access and commercial strategies for products in early development, pivotal study planning, launch, and post launch lifecycle management. He has addressed business challenges from a variety of vantage points including Global, European, and US roles. He has built highly engaged teams, business processes, and a knowledgebase that enables the execution of commercial strategies with a focus on oncology and cell and gene therapies. As Head of Commercial Strategy and Operations for Bayer CGT, Doug is responsible for connecting large pharmaceutical company commercial scale and footprint with small biotech innovation within the context of an “arms-length” operating model. He enjoys working in new spaces with a high level of uncertainty and the associated challenge of making sense out of ambiguity.

Edward de Nor is an experienced private equity executive with over 25 years of financial and principal investing experience focused on the European and North American mid-market. With former roles including Partner at G Square Healthcare Private Equity, Founder at Carrycastle and as Head of UK & Northern European private equity at Goldman Sachs PIA, he has focused his career on supporting mid-market companies to grow on both sides of the Atlantic. De Nor began his career with IBM in engineering and corporate development, working then with technologies that are prevalent in the healthcare industry today. He currently sits on the boards of Biocare Medical, Velocity and FairJourney Biologics and previously BioAgilytix and DDC until their successful exits.

Chris Dodd, MD has overall accountability and oversight of all clinical functions for Emcara Health and leads the company’s effort to scale its national network of home-based advanced primary care medical practices. He has a strong track record of creating successful partnerships with health plan and provider group partners as well as deep experience delivering care to vulnerable populations in the United States and around the world in resource-poor settings. Prior to joining Emcara Health, He served in a variety of executive and senior leadership roles, including value based medical groups and federally qualified health centers. Dodd graduated from Vanderbilt University, earned his Doctor of Medicine degree from Boston University School of Medicine, and completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. He lives in Seattle with his wife and two daughters and enjoys early morning swims and traditional Greek folk dancing.

Robert Fields, MD is a family medicine physician and serves as the EVP, Chief Population Health Officer (CPHO) at Mount Sinai Health System in New York City. In this role, Fields leads system strategy and operations for population health, fee for service and value-based contracting, medical economics, and population health analytics. The Mount Sinai network of hospitals and physicians manages $3.5 billion dollars of medical spend for over 450,000 patients in the downstate region including global risk and shared savings arrangements in all lines of business. He began his career as an independent primary care physician with a particular concentration on underserved Latino patients in Western North Carolina. He came to Mount Sinai in March of 2018 as the SVP and CMO for Population Health and has led the redesign of clinical operations for value including care management, provider engagement, quality programs, remote monitoring and condition management, social determinants, and other aspects of the system’s population health strategy. He was promoted to Chief Population Health Officer in 2021 where in addition to his previous role, is now also developing the contracting and strategic pricing strategy and operations for the system.

Lisa Fitzpatrick, MD is a physician, medical epidemiologist, and is the founder and CEO of Grapevine Health, a digital health media company she established to build trust and improve patient engagement among Medicaid patients. She began her public health career in 1998 as a member of the CDC’s elite Epidemic Intelligence Service. She has served as a foreign diplomat in the Caribbean, an academic researcher, and the former chief medical officer for the DC Medicaid program. Dr. Fitzpatrick is a member of the Institute of Medicine/ National Academy of Sciences Roundtable on Health Literacy and an Aspen Institute Health Innovator Fellow.

Aaron Friedkin, MD is the Chief Revenue Officer of Homeward, a company focused on improving access to high-quality, affordable comprehensive care in rural communities. As part of the founding team of Homeward, Friedkin uses his experience as a former health plan executive to establish strategic partnerships and expand Homeward’s market presence by executing value-based contracts with leading national health plans. Previously Friedkin was the senior vice president of Care Delivery Transformation at Blue Cross Blue Shield of Michigan where he was accountable for the strategy, execution, and management of new provider partnerships intended to transform the way care is delivered by aligning incentives across payers, providers, and members. Before joining BCBSM, he supported large national employers on their healthcare strategies at Blue Cross Blue Shield of Minnesota and developed strategies for both payers and providers as a management consultant with McKinsey & Company. Friedkin is a board-certified radiologist, with subspecialty certification in pediatric radiology. He completed his diagnostic radiology residency at the University of Michigan and his pediatric radiology fellowship at Boston Children’s Hospital. He earned his Doctor of Medicine and Master of Science in Anatomy at Case Western Reserve University.

Tamir Gotfried brings over 20 years of international sales and business development experience in enterprise technology solutions. Prior to joining TytoCare, Gotfried served as the CRO of Bringg, a leading last-mile delivery platform, driving the commercial organization to scale. He also held leadership roles at Starlims, later acquired by Abbott Diagnostics, where he led commercial operations for the Abbott Informatics Division. He earned an MBA from the University of Miami and a B.Sc. in Industrial Engineering from Florida International University.

Eric Grossman is the Chief Commercial Officer of Softheon. Grossman spent his entire career in healthcare technology helping health plans drive value from their software investments. Grossman is the founder and CEO of multiple innovative health tech companies dedicated to improving clinical and operational processes including Connecture and NextHealth (sold Softheon this year). He also worked with Cognizant/TriZetto and led their Voice of the Customer, Consumerism, and Analytics business units.

Manisha Shetty Gulati is driven by a deeply rooted passion to empower the operational growth and performance of healthcare organizations through the adoption and acceleration of innovative technologies. As Chief Growth Officer at Commure, Gulati spearheads the company’s growth and partnerships strategy, driving go-to-market, revenue growth, and the partner ecosystem through alignment of the marketing, sales, and business development organizations. Before joining Commure, Gulati held leadership positions across the healthcare ecosystem, including serving as the Chief Operating Officer at Clarity Health Solutions, where she brought to life the company’s mission to deliver better care through advanced analytics and software solutions. She also worked as a partner at McKinsey & Company in the health systems, medical products, and life sciences practices in the US and EMEA, focusing on commercial growth and innovation with impact. Gulati currently serves as vice chair of the board of directors at ReSurge International, a nonprofit humanitarian aid organization providing reconstructive surgical care in developing countries worldwide, and as a member of the board of the directors for Model N, a revenue lifecycle management software company. She holds two master’s degrees in business administration and public administration from Harvard University.

Courtney leads our U.S. health team with deep expertise in biomedical innovation and health policy. She directs corporate reputation and public affairs campaigns to advance medical research, support vaccine policies, promote consumer health education and elevate the importance of healthcare investment around the world. Partnering with organizations including Amgen, AstraZeneca, Cigna, Johnson & Johnson, Lilly and Merck, Courtney manages thought leadership and positioning efforts to educate policymakers, healthcare providers and advocacy groups on drug pricing, mental health, cardiovascular disease and patient access. She has provided counsel to the Johns Hopkins Bloomberg School of Public Health, BIO, IFPMA and others on strategies around COVID-19, antibiotic resistance, building vaccine confidence and other public health issues. Courtney led efforts to elevate the Robert Wood Johnson Foundation and Wellcome Trust with media and health and policy experts. She also oversaw consumer education initiatives with the Consumer Healthcare Products Association including the Stop Medicine Abuse campaign to reduce teen OTC cough medicine abuse and Up and Away and Out of Sight with the CDC to prevent accidental overdoses in young children. Prior to joining Edelman, Courtney served as vice president, Government Affairs and Communications, for Washington Health Advocates, where she focused on coalition building and federal appropriations strategies for NIH, CDC and FDA. Courtney also managed advocacy programs for the Association of Clinical Research Organizations, collaborating with stakeholders in the U.S., EU and Asia on clinical research policies and education.   Courtney is a member of Chief and has served on the Board of the Center for Study and Information on Clinical Research Participation (CISCRP). She is active in efforts to raise awareness about bone marrow stem cell donation and provide support to blood cancer patients and caregivers. She holds a B.A. in Political Science from Goucher College in Baltimore, MD.

Howard J. Jacob, Ph.D. is the Vice President and Head of Genomics and Data Integration at AbbVie. He joined AbbVie in January 2018 to lead one of the largest Genomics Research Center efforts in the field with access to over one million genomes and clinical data. In addition, he leads AbbVie’s R&D-wide Data Integration Program (called Convergence) which brings together all types of data to create knowledge to solve and ultimately improve treatment for patients. The Convergence team recently launched the AbbVie Research Collaborative, a health data platform that enables patients to share their health data with AbbVie researchers to help advance the development of new medicines. Prior to his role at AbbVie, he led the whole genome sequencing core for the NIH-funded Undiagnosed Disease Network, the clinical teams at the world's first stand-alone genomic medicine clinic, and a whole genome clinical sequencing lab. He founded four companies and is on the advisory boards for numerous academic and commercial organizations. As a pioneer and leader in genomics, in 2009, Jacob and his team at the Medical College of Wisconsin were the first in the world to use genomic sequencing to save the life of a patient, Nicholas Volker. Nicholas’ story was highlighted in a Pulitzer Prize winning series in the Milwaukee Journal Sentinel. Jacob has published over 250 peer-reviewed articles. He earned his Ph.D. at the University of Iowa and then completed a post-doc with Eric Lander and Victor Dzau at MIT, Harvard, and Stanford.

Minoo Javanmardian, PhD is a Chicago-based senior partner at Oliver Wyman and a member of Health and Life Sciences Team. She is a recognized thought leader in provider and payer sectors. She has served many CEOs, C-Suite executives, and Board of Directors across multiple health system sectors including academic medical centers, faith-based systems, regional players and community players. She has also served many payer clients including Blue Cross Blue Shields in different regions Her focus is on strategy development and implementation of resulting capability systems to ensure successful execution. While supporting clients from strategy to execution she has also led several engagements around strategic cost transformations through business process redesign, operating model (governance and organization), M&A strategy and post-merger integration.

Ricardo R. Johnson is Executive Vice President of Enterprise Strategy and Emerging Business of CareFirst BlueCross BlueShield and leads Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield (CareFirst). Johnson is part of a dynamic team that creates, partners with, and invests in companies who are improving affordability, convenience, and equity in healthcare. Ricardo has a deep understanding of the healthcare industry — from product development and operations to strategy and business growth. Before Healthworx, he worked as the Special Assistant to the CEO of CareFirst where he was senior advisor in both strategic and operational functions within CareFirst. Prior to that Johnson practiced law, including as Associate General Counsel of CareFirst, handling a variety of healthcare and corporate matters. He holds a law degree from University of Maryland and an undergraduate degree from La Salle University.

Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company on a mission to change the way the world treats weight. In two years, Calibrate has raised more than $125 million from leading investors, including Founders Fund, Tiger Global, Optum Ventures, Forerunner Ventures, Threshold Ventures, and Redesign Health, and has published clinically-reviewed results from its One-Year Metabolic Reset that exceeded the best outcomes from clinical trials across all metabolic markers. Calibrate was recognized as a World Economic Forum Technology Pioneer in 2021 and by Fast Company’s World Changing Ideas in 2022. Prior to Calibrate, Isabelle led business operations, growth, and strategic partnerships & communications at Capsule, a technology business rebuilding the pharmacy from the inside out. Before Capsule, she worked at beloved consumer brands in London and New York. Isabelle began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania. She was selected to the Forbes 30 Under 30 list in 2015.

Bio coming soon

Kelsey Maguire is a Managing Director at Sandbox Industries and the Blue Venture Fund. She currently serves on the Board of CirrusMD, Ideal Option, Insightin Health, Origin Physical Therapy, Quilted, and Wayspring. She also helps manage the Fund’s investments in Everly Health, Lumiata, and axialHealthcare. Prior to Sandbox, Kelsey was the Head of Eligibility and Launch Operations at health insurance startup, Collective Health, where she led several teams focused on launching new clients. She was previously an associate at the growth private equity firm TA Associates and began her career as a M&A banking analyst at Deutsche Bank. Kelsey holds an A.B. in History & Literature from Harvard

Snezana Mahon is Chief Operating Officer of Transcarent, leading the company’s operational functions, and product development. She brings over 15 years of progressive experience in the healthcare industry including pharmacy benefit management, product development & management, Government Programs, vertical & horizontal enterprise integrations, clinical innovation and operational excellence. At Express Scripts, she held various leadership and management positions within the Clinical Product and Government Programs organization. Most recently as Vice President and General Manager Evernorth Care Solutions, she was responsible for all clinical initiatives and utilization management programs that help make the use of prescription medications safer, more affordable and more accessible for patients and payers. Previously, Mahon was Senior Director of Medicare strategy, where she guided Medicare Advantage and Part D plans on CMS guidelines, regulations and Star Ratings requirements. She is a registered pharmacist and holds a doctorate in pharmacy from the St. Louis College of Pharmacy. Her earlier retail pharmacy career included positions with Walgreen Company. Mahon speaks at a wide array of healthcare forums and has been published in journals including Managed Healthcare Executive and Fierce Health Care.

Sarah Marche, SVP of Pharmacy and Clinical Market Strategies, is responsible for Highmark’s Pharmacy Benefit Business, including Clinical and Specialty Pharmacy, Pharmacy Product, Operations, and Pharmacy Vendor management. She leads a team of clinical resources that includes nurses, pharmacists, and medical directors responsible for consulting with our clients and advising our customers on how they can optimize clinical and cost outcomes related to their medical and pharmacy benefits through an integrated benefit. She joined Highmark Inc. as a Clinical Pharmacy Specialist in 2005 with a focus on Formulary and Utilization Management for the Commercial and Medicare Part D lines of business ensuring Highmark provided coverage of clinical and cost-effective drug therapy.

Prior to assuming the role of Civica's President and CEO, Ned served as its Chief Operating Officer where he provided day-to-day oversight for Civica’s growing manufacturing efforts, including the building of Civica’s state-of-the-art essential medicines manufacturing facility in Petersburg, VA, expected to be operational in 2024. Ned has led efforts to secure manufacturing partnerships for over 60 sterile injectable medications that hospitals use daily, helping Civica supply essential medicines and address chronic drug shortages, unpredictable price inflation, and predatory pricing. He has also been deeply involved with Civica’s commercial team and stakeholders, ensuring hospitals have the medicines they need when they need them. Most recently, McCoy orchestrated the partnership with Civica’s affordable insulin development partner, GeneSys Biologics, with the plan to bring Civica biosimilar insulins to market beginning in 2024. Prior to this role, Ned was the Chief Business Development Officer, responsible for developing and signing long term supply partnerships to prevent drug shortages and establish fair pricing.

Barbara Montresor is an accomplished marketer and communications strategist, passionate about building world-class brands and teams. At Healthfirst, one of the nation’s largest not-for-profit health insurers, she oversees branding, marketing, customer experience, corporate communications and retail. She devotes much of her time working at the intersection of business strategy, brand, consumer experience and digital transformation, guiding efforts to make healthcare easier and more equitable for Healthfirst’s 1.8 million members. Montresor also serves on the Board of the Healthfirst Foundation. Prior to joining Healthfirst in 2017, she served as Senior Vice President of Marketing and Communications at Welltower, Inc., a real estate investment trust that invests in senior housing, assisted living and memory care communities, acute care facilities and medical officer buildings. She previously spent 13 years in corporate communications leadership roles at Johnson & Johnson, where she developed and implemented campaigns for global brands including: ACUVUE Brand Contact Lenses; ETHICON surgery products and the consumer healthcare brands of McNeil, including Tylenol, Motrin and Zyrtec. Throughout her career Montresor has championed the importance of employee engagement as a building block for supporting brands from the inside out, having served in human resource roles earlier in her career at Lucent Technologies. Barbara holds a Bachelor of Arts and Master of Arts in Political Science from Boston College.

Aetna’s National & Enterprise Accounts organization is comprised of the team that partners with Aetna’s largest clients who typically sponsor their own health care plans and wish to work with a company to work alongside them to achieve a healthy and productive workforce by focusing on not only associates but also their families and communities. For this select set of clients, Brigitte Nettesheim's focus is on furthering the integration of our enterprise assets, driving growth, accelerating cross-sell opportunities, and consistently staying ahead of changing client needs. Nettesheim is a transformative healthcare leader with an extensive track record across payer, provider, technology and communities of continually improving both access to and the affordability of quality healthcare with a unique array of leadership experience across private and public sector organizations ultimately focused on the consumers of health services and dedicated to community efforts to address health disparities. She earned a master's degree in business administration from the Kellogg School of Management at Northwestern University where she concentrated her studies in health industry management. She received her bachelor of science in economics with a minor in systems engineering from the United States Military Academy and served in the United States Army, departing with the rank of Captain.

Alex Oshmyansky, MD is the founder and CEO of the Mark Cuban Cost Plus Drug Company. Oshmyansky founded the Mark Cuban Cost Plus Drug Company after being incensed by the skyrocketing costs of generic drugs for his patients. Oshmyansky graduated from the University of Colorado at Boulder at the age of 18 with a BA in Biochemistry. He went on to earn an MD at the Duke University School of Medicine and a PhD (DPhil Oxon) at Oxford University in Mathematics as a Marshall Scholar. He completed a surgical internship at the Brigham and Women’s Hospital / Harvard Medical School. Oshmyansky went on to a residency in diagnostic radiology and a fellowship in pediatric radiology at the Johns Hopkins Hospital. He then served as an adjunct faculty member at the Stanford University School of Medicine and continues to practice as an emergency radiologist. While in grad school, Oshmyansky founded a startup dedicated to reducing the rates of nosocomial diseases in hospitals, Altitude Medical. That company has been continuously operating for over 14 years.

Kash Patel is the Executive Vice President and Chief Digital Information Officer, Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network. Mr. Patel has more than 25 years of experience in technology leadership, ranging from start-ups to multinational corporations and is a seasoned leader in health care with a strong focus on innovation and building great teams. Before HMH, Kash was the Vice President and Chief Digital Technology Officer at Penn Medicine, where he led the world-class Pearlman School of Medicine Information Technology team. There, he supported the complex areas of research, clinical trials, manufacturing, high-performance computing, informatics, genomic science, and many others. In addition, Kash was the Vice President for Population Health and Analytics at Mount Sinai Health system where he led the technology strategy in support of the institution's shift from fee for service to more risk-based pricing.

Gabriela Perez is the Chief Commercial Officer at Big Health, a digital therapeutics company providing safe and effective non-drug alternatives for the most common mental health conditions including insomnia and anxiety. In addition to her role at Big Health, Gabriela is a partner at NextGen Ventures and has been starting and building technology-enabled healthcare services companies since 1999. Her entrepreneurial career started as part of the founding team at Best Doctors, a pioneer in the market of global e-second opinions, which operated in 45 countries. During her tenure, Gabriela held multiple leadership positions across product, marketing, partnerships and global sales divisions until the company was acquired by Teladoc (NYSE: TDOC) in 2017. Following Best Doctors, Gabriela led the recapitalization of Attune Hearing which she evolved into the largest audiology company and multi-clinic network in Australia. Most recently, Gabriela was EVP & General Manager at Ovia Health, the largest women & family digital health company in the United States, responsible for triple digit growth which culminated in an exit in 2021. Her passion for entrepreneurship extends beyond the workplace and includes investing in next-generation connected health ventures and mentoring at Harvard Innovation Labs in Boston. Gabriela presently seats on the investment board of the Florida Institute for Commercialization of Research and Technology and is an Advisor and Investor in multiple health tech organizations. Gabriela is an alumna of Stanford University's Design School and Harvard Business School.

Megan Reyna is the System Vice President of Practice Transformation and Quality Improvement for Advocate Aurora Health. Under her leadership, Ms. Reyna’s team leads the value-based care practice support, government programs, quality improvement, and chronic condition management teams to assist the organization in achieving national quality and value-based care outcomes across Illinois and Wisconsin. In her role, she oversees the operations of two ACOs that continue to achieve significant taxpayer savings and provide high quality care through the Medicare Shared Savings Program (MSSP) and continues to help the organization evaluate new payment models for success. She has been a featured speaker and panelist on the topic of ACOs and value-based care at numerous national conferences, and currently serves as Chair of the National Association of ACOs (NAACOS) Quality Committee. A registered nurse by background, Ms. Reyna received her MSN from the University of Illinois Chicago and lives in Western Springs, IL with her husband and two children.

Hector Rodriguez is an experienced solution strategist, technologist, and prior Chief Information Security Officer. He has worked for over 25 years in the health industry with provider, health plan, and life sciences organizations. As an Executive Security Advisor at AWS his work focuses on leveraging modern technology as an innovative and transformative catalyst to accelerate and support an organization’s ability to live their mission. Hector works with organizations to enable a secure, private, and compliant cloud driven transformation.

Amit Sabharwal is a Senior Partner at Lippincott, a division of Oliver Wyman Group. He co-leads Lippincott’s Marketing and Customer Strategy practice and oversees the firm’s Customer Sciences capabilities, including advanced marketing sciences and data sciences. Amit’s work has spanned nearly two decades, five continents, and a range of industries. He has consulted to hallmark brands – including Bank of America, Coca-Cola, CVS, eBay, and Walmart – and has additionally worked broadly across the healthcare ecosystem – including with leading hospital systems, payers, digital health platforms, and healthcare advocacy organizations. He supports clients to drive profitable growth through the development of customer-centric marketing strategies, including new business design, brand, customer experience, and product strategies. Prior to joining Lippincott, Amit spent time in management consulting, technology product management, venture investing, and economic development.

Erin Satterwhite's passion to drive positive change in healthcare goes as far back as she can remember, as both a patient and advocate, where the calling to create a more empathetic and effective healthcare experience has been her life's work. Today she oversees the strategy and commercial efforts across the Optum Integrated Pharmacies, as well as the new pharmacy and distribution businesses Optum Frontier Therapies, a rare disease and emerging therapy focused pharmacy, and Optum Specialty Distribution, a supply chain innovation to support better patient and provider access to specialty medications. Previously, she led organizations at Bayer Healthcare, 3M Company and Blue Cross Blue Shield to drive innovation and commercialize new products and services across consumer and professional health care. Satterwhite has six issued patents, has authored multiple publications, and holds certifications in Business Model Innovation and Outcome Driven Innovation. She attended the University of Minnesota for her bachelor's and master's degrees in biochemistry and biological science, respectively. She is involved in Special Olympics, and a board member for Clal, a New York based think-tank and innovation incubator focused on 'making Jewish a public good.'

Mario Schlosser is the CEO and co-founder of Oscar, a leading insurer built to make health care easy. Under his leadership, Oscar develops seamless technology and provides personalized support to help more than 540,000 members navigate their health care. Oscar has been recognized as one of Fast Company’s most innovative companies in health, one of CNBC’s top 50 disruptors, and one of TIME’s most influential in health care. Previously, he co-founded the largest social gaming company in Latin America, where he led the company's analytics and game design practices. Prior to that, Schlosser was a Senior Investment Associate at Bridgewater Associates and worked as a consultant for McKinsey & Company in Europe, the U.S. and Brazil. Schlosser also spent time as a visiting scholar at Stanford University, where he wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed the EigenTrust Algorithm to securely compute trust in randomized networks. In May 2019, Schlosser and his co-authors, Sepandar D. Kamvar (Mosaic Building Group Inc) and Héctor Garcia-Molina (Celo), received the prestigious Seoul Test of Time Award from the International World Wide Web Conference Committee (IW3C2) for this work. Schlosser holds a degree in computer science with highest distinction from the University of Hannover in Germany and an MBA from Harvard Business School.

Elana Schrader, MD serves as GuideWell’s Senior Vice President, Health Care Services and President of GuideWell Health. In this role, Schrader leads the health care delivery business within the GuideWell family of companies. She also is responsible for the development of the overarching clinical strategy for Florida Blue and leading clinical activities including care management, health promotions and wellness, pharmacy, quality, and clinical retail health initiatives. Since joining GuideWell and Florida Blue, Schrader has served in a number of transformational leadership roles. Most recently, she served as Chief Medical Officer, with responsibility for Population Health Management and prior to that was accountable for the design and development of new and innovative health solutions and the management of the product portfolio for all commercial health insurance business as Vice President of Product. Schrader also initiated and established Florida Blue’s Six Sigma and continuous improvement office, serving as its Vice President. Prior to this role, she served as Medical Director for the care and quality program for retail health care, and as Vice President of Provider Services with accountability for overseeing the company’s relationship with more than 30,000 physicians and hospitals across the state of Florida. Earlier in her career, she was Vice President of Enterprise Planning and Performance Management, accountable for business and operational planning, business process management, cost management, and procurement. Prior to joining Florida Blue, Schrader served as the Medical Director for Columbia/HCA Memorial Hospital and had a private practice in internal medicine in Ponte Vedra Beach, Fla.

Roberta L. Schwartz is the Executive Vice President and Chief Innovation Officer of Houston Methodist Hospital, one of the Texas Medical Center’s founding institutions. She is responsible for overseeing all operations at the 946-bed hospital, which has been named by U.S. News & World Report as the No. 1 hospital in Texas for 10 straight years and has also been named to the publication’s prestigious “Honor Roll” of America’s best 20 hospitals five times. In her role as chief innovation officer, Schwartz is responsible for advancing and expanding Houston Methodist’s digital innovation platforms, including telemedicine, artificial intelligence and big data. Prior to joining Houston Methodist, Schwartz worked as director of business development for Mount Sinai School of Medicine in New York as a consultant and project manager for several academic medical centers for APM/Computer Sciences Corporation and for CMS (HCFA). Schwartz earned a master’s in health science from Johns Hopkins University and an honors undergraduate degree from Barnard College at Columbia University. She has a Ph.D. from the University of Texas School of Public Health. Schwartz has been recognized nationally for her professional and non-profit work. She was most recently recognized by Modern Healthcare’s Top 25 Women Leaders as one of its 10 Women to Watch. She is also involved in many non-profit organizations such as Lifegift OPO, Robert M Beren Academy and the UOS Synagogue, Young Survival Coalition and many breast cancer organizations.

Rosemary Sheehan currently serves as the Chief Human Resources officer for Mass General Brigham, an integrated academic healthcare system which includes Allways Health Partners, 13 hospitals and 4 physician organizations. Mass General Brigham is the largest employer in Massachusetts with over 82,000 employees. Ms. Sheehan partners with executive leadership to develop internal growth, expand/build people and process capabilities, create/drive a culture of innovation, continuous improvement and operational excellence, and strengthen the strategic business alignment of the HR function. Prior to her role as the CHRO, Sheehan served as the Vice President of Revenue Cycle Operations (RCO), which processed gross patient service revenue of over $13 billion and cash collections of nearly $6 billion for all Partners Hospitals. In addition to her operational role, she was the Executive Director of the Partners eCare project, responsible the for implementing and governing Epic’s revenue and clinical system across Partners. For nearly thirty years, she has served in a variety of leadership roles in healthcare including, among others, as the Executive Director of the Professional Billing Office of the Massachusetts General Physicians Organization. She has also served in leadership roles at Caritas Norwood Hospital in Norwood, MA. Ms. Sheehan has extensive experience in healthcare revenue cycle operations, staff development and leadership, new business development, regulatory compliance, and complex project management.

Surya Singh, MD is a seasoned healthcare executive with leadership experience across large public and private corporations, small entrepreneurial companies, and non-profits. He currently serves as a senior advisor and/or medical officer for organizations active in designing and implementing value-based reimbursement programs, with a particular focus and expertise on complex, novel, high-cost therapies for rare conditions. These organizations include Emerging Therapy Solutions, Coeus Holdings, and the Institute for Clinical and Economic Review. Previously, Singh was Chief Medical Officer & Corporate Vice-President at CVS Health Specialty, Chief Medical Officer and Head of Product at Proventys, (acquired by McKesson Corporation), Chief Medical Officer at D2Hawkeye (now Verisk Health) and was a consultant at McKinsey and Company. Singh is licensed and board certified in internal medicine.

Amy Dirks Stevens is an entrepreneurial healthcare leader focused on accelerating business performance through innovative enabling technology. She has been a health system C-suite leader (COO, CSO) in not-for-profit and large for-profit health systems; President of one of the nation’s 1st CINs; and a founding executive of AVIA, the vanguard network of health systems and payors driving digital innovation. She is GM for Provider Performance at Innovaccer, a healthcare data activation and analytics platform ranked #1 by KLAS and expanding global reach. She partners with provider and risk-bearing entities to digitally-enable their business performance. Leaders adopt the Innovaccer platform to reduce costs, improve workforce retention and automate workflows, optimize traditional and value-based care contract performance, diversify revenue, and engage their providers, populations, and patients.

Jack Stoddard is currently the Chief Executive Officer of Patina, which is reinventing primary care from the ground up to provide the healthcare and aging experience that older adults and their loved ones deserve. The company is backed by a syndicate of leading venture and growth equity firms including: Andreessen-Horowitz, Google Ventures, F-Prime, Rock Springs, and Viking Global. Throughout his career, Stoddard has had senior leadership roles in several transformational health care companies, including: Haven (as founding COO), Accolade (as founding COO), Optum (as SVP, Employer Solutions & International), Health Dialog, and The Advisory Board. He has also served as an Executive Advisor to leading private equity firms, including: Clayton Dublier and Rice, Stone Point, Carlyle, and New Mountain Capital. Stoddard serves as Chairman of Board at Eden Health, a primary care and navigation company serving small and medium employers, and backed by Insight Partners, Greycroft, and Flare. He served for seven years on the Board of Trustees of the Philadelphia Outward Bound School.

Tammy Sun is the Co-founder and CEO of Carrot Fertility, the leading global fertility healthcare and family-forming benefits provider for employers and health plans, built to support employees through their lifelong fertility healthcare journey. Carrot's clinically-managed program includes fertility preservation like egg and sperm freezing, IVF, donor and gestational carrier services, adoption, pregnancy, menopause, and low testosterone support; Carrot Rx®, a premium pharmacy experience at significant savings; and the Carrot Card®, a flexible fertility benefits card employees can use to pay for their care. Sun was inspired to create Carrot after she spent $35,000 of her personal savings to undergo egg freezing. Sun has had a successful career in marketing, technology, and politics. Most recently, she was the Director of Partnerships at Evernote. Prior to Evernote, she spent a decade in politics, where she served as a presidential appointee at the Federal Communications Commission during the Obama administration. She also held roles at the Clinton Foundation and The White House.

Melissa Swift leads is a workforce transformation leader at Mercer advising organizations on people-focused transformations to enhance the workplace experience. She led global workforce transformation at Korn Ferry, helping top companies reshape their organizations, and led sustainability and cleantech transformation at Deloitte.

Heiyab Tessema is a Partner in Oliver Wyman’s Digital and Health and Life Sciences practices, based in New York. He has over a decade of digital transformation, product management, and technical delivery experience across healthcare, retail, financial services and the public sector. He helps clients develop and execute innovation strategies amidst existing technology and operating model constraints and his experience includes process digitization, data pipelining, advanced analytics and user interface design in back-office, B2B2C and D2C contexts. Prior to joining Oliver Wyman, Tessema worked as a Lead Business Architect at Agora Group, Inc. as well as a Senior Project Engineer at Savin Engineers.

Glen Tullman is the CEO of Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families. Transcarent empowers consumers with the kind of information, guidance and access that leads to better care, better outcomes, and more cost-effective decisions for everyone. Tullman is the former Executive Chairman, CEO, and Founder of Livongo Health, the first at-scale consumer digital health company to truly empower people with chronic conditions to live better and healthier lives using data science. In his final year, he led Livongo through the largest consumer digital health Initial Public Offering in history, a secondary offering, a convertible debt offering that raised over $550 million, and the industry’s largest merger to date between Livongo and Teladoc Health, valuing Livongo at $18.5 billion and beginning a new era of consumer-centric virtual care. A visionary leader and entrepreneur, Tullman previously ran two other public companies that changed the way healthcare is delivered. During his time as CEO of Allscripts, the Company was the leading provider of electronic prescribing, practice management, and electronic health records. Glen led Allscripts IPO and Secondary offerings. Prior to Allscripts, he was CEO of Enterprise Systems, the leading resource management systems for hospitals, which he also took public and then sold to McKesson/HBOC. Before entering healthcare, Tullman served as President and COO of CCC Information Systems, a provider of computerized systems for the property and casualty insurance sector. Tullman is also one of two Founding Partners at 7wireVentures, one of the highest returning venture capital funds in Illinois. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic-condition epidemic facing our country.

Todd Van Tol is the Executive Vice President of Health Care Value for Blue Cross Blue Shield of Michigan (BCBSM). He is responsible for provider contracting and network management, medical and pharmacy management as well as end- to-end management of the total cost and quality of care for individual and group customers. Previously, he led the plan's Commercial Group business with responsibility for the Autos, Key & Large, Middle & Small Group, and Private Exchange lines of business. Prior to joining BCBSM in July of 2017, Todd served as a Partner and North American practice leader for the Health and Life Sciences business of Oliver Wyman where he led the firm's efforts across Payer and Provider clients.

Ameesh Vakharia is Executive Vice President and Chief Strategy & Brand Officer for USAA and a member of the Company’s Executive Council. His organization brings together Strategy, Member Insights, Marketing, Communications, Military Affairs, Corporate Development, Digital, Design, Innovation, DE&I, ESG and Corporate Responsibility, including the USAA Foundation and the USAA Educational Foundation. Under Ameesh's leadership, the team guides the Fortune 100 company's member-centric strategy and innovation while protecting, promoting, and advocating for USAA's treasured, 100-year-old brand. He joined USAA in June 2021 after holding leadership positions in the financial services industry for the past 20 years.

Bio coming soon

Jeff Wessler, MD is a Virtual Cardiologist and the Founder and CEO of Heartbeat Health. Heartbeat Health delivers virtual cardiology via remote diagnostics, telemedicine, and management for cardiac patients with atrial fibrillation, vascular disease, and heart failure. Wessler graduated from Williams College, received an MPhil in public health and epidemiology from Cambridge University, and his MD from Harvard Medical School. He completed a cardiology fellowship at New York Presbyterian-Columbia, being named Chief Resident of the medicine program. He is currently an assistant professor of medicine at Northwell Health. Wessler is a father, an avid squash player, and was raised in Boston.

Ian Wijaya leads Lazard’s North American Healthcare Services M&A and strategic advisory practice (he is based in New York). An investment banker for 20 years, Ian joined Lazard in 2011 and co-founded the Firm’s healthcare services practice, which spans payors, providers, healthcare technology companies and the supply chain. Ian has experience in a wide range of corporate finance transactions, including mergers and acquisitions, leveraged buyouts, recapitalizations, financial restructurings and reorganizations, joint ventures, and other matters and has advised on several of the largest and most transformative M&A transactions in healthcare, including three of the largest in recent history (sale of Aetna to CVS for $77bn, sale of Express Scripts to Cigna for $67bn, and Roche’s $49bn squeeze-out of Genentech). Ian regularly advises senior executives and Boards of Directors of healthcare companies regarding the strategic and financial implications of a broad range of trends and dynamics facing payers, providers, biopharma and others, including regarding ways to innovate and transform the landscape, as companies seek new ways to improve quality of outcomes, reduce costs to the system and improve patient/member satisfaction. Mr. Wijaya is an avid musician, composing original classic rock and funk songs in his home studio, on the guitar, bass, piano and drums.